share_log

Regeneron Pharmaceuticals | 8-K: Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

SEC announcement ·  Feb 2 07:20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more